Cargando…
Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
Alzheimer’s disease (AD) is a neurodegenerative disease that is clinically characterized by progressive cognitive decline. More than 200 pathogenic mutations have been identified in amyloid-β precursor protein (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2). Additionally, common and rare varian...
Autores principales: | Hsu, Simon, Pimenova, Anna A., Hayes, Kimberly, Villa, Juan A., Rosene, Matthew J., Jere, Madhavi, Goate, Alison M., Karch, Celeste M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236786/ https://www.ncbi.nlm.nih.gov/pubmed/32087291 http://dx.doi.org/10.1016/j.nbd.2020.104817 |
Ejemplares similares
-
Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012) -
Correction: Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012) -
APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
por: Xiao, Xuewen, et al.
Publicado: (2021) -
APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
por: Giau, Vo Van, et al.
Publicado: (2019) -
Amyloid-β(1–43) cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
por: Perrone, Federica, et al.
Publicado: (2020)